CDH2 and breast carcinoma: We selected a series of epithelial (panCK/CK18/ZO-1/E-cad) and mesenchymal marker (N-cad/Vimentin) markers which were first confirmed across breast cancer cell lines (Supplementary Figure S3A,B).